共 50 条
- [34] Dapagliflozine is now available for patients with T2DM (cardiovascular and/or renal risk) CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2020, 24 (03): : 119 - 119
- [36] Preptin as a Potential Marker in Iraqi Newly Diagnosed T2DM and T2DM with Cardiovascular Disease JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2024, 10 (02): : 102 - 105
- [40] Diastolic Pressure and ACR Are Modifiable Risk Factors of Arterial Stiffness in T2DM Without Cardiovascular Disease JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (09): : E3857 - E3865